Radosław Mlak

1.3k total citations
109 papers, 892 citations indexed

About

Radosław Mlak is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Radosław Mlak has authored 109 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 31 papers in Molecular Biology and 30 papers in Oncology. Recurrent topics in Radosław Mlak's work include Nutrition and Health in Aging (19 papers), Lung Cancer Treatments and Mutations (18 papers) and Gastric Cancer Management and Outcomes (17 papers). Radosław Mlak is often cited by papers focused on Nutrition and Health in Aging (19 papers), Lung Cancer Treatments and Mutations (18 papers) and Gastric Cancer Management and Outcomes (17 papers). Radosław Mlak collaborates with scholars based in Poland, United States and Germany. Radosław Mlak's co-authors include Teresa Małecka‐Massalska, Tomasz Powrózek, Iwona Homa‐Mlak, Anna Brzozowska, Janusz Milanowski, Paweł Krawczyk, Kamal Morshed, Wojciech Polkowski, Karol Rawicz‐Pruszyński and Kamila Wojas‐Krawczyk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Radosław Mlak

99 papers receiving 882 citations

Peers

Countries citing papers authored by Radosław Mlak

Since Specialization

Citations

This map shows the geographic impact of Radosław Mlak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radosław Mlak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radosław Mlak more than expected).

Fields of papers citing papers by Radosław Mlak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radosław Mlak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radosław Mlak. The network helps show where Radosław Mlak may publish in the future.

Co-authorship network of co-authors of Radosław Mlak

This figure shows the co-authorship network connecting the top 25 collaborators of Radosław Mlak. A scholar is included among the top collaborators of Radosław Mlak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radosław Mlak. Radosław Mlak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Textbook outcomes among patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies in an Eastern European population 2025 ·Journal of Gastrointestinal Surgery ·(unknown), (unknown), (unknown), Radosław Mlak, (unknown), Wojciech Polkowski, (unknown), (unknown), (unknown), (unknown), Andrew A. Gumbs, (unknown), Timothy M. Pawlik, Kamil Torres, Paweł Rybojad, Karol Rawicz‐Pruszyński	1
2	Sentinel lymph node biopsy in breast cancer: the role of ICG fluorescence after neoadjuvant chemotherapy 2025 ·Breast Cancer Research and Treatment ·(unknown), (unknown), Radosław Mlak, (unknown), (unknown), (unknown), (unknown), (unknown), Wojciech Polkowski, Karol Rawicz‐Pruszyński, Andrzej Kurylcio	1
3	Quantification of Citrullinated Histone H3 as a Marker for Neutrophil Extracellular Traps Correlated to Clinical Characteristics of Patients with Systemic Lupus Erythematosus 2025 ·Archivum Immunologiae et Therapiae Experimentalis ·(unknown), Iwona Homa‐Mlak, (unknown), Radosław Mlak, Maria Majdan, Teresa Małecka‐Massalska	1
4	Proximal gastrectomy as an alternative to total gastrectomy in patients with advanced proximal gastric cancer: propensity score matching analysis of the 2-center study in European population 2025 ·Journal of Gastrointestinal Surgery ·(unknown), (unknown), Radosław Mlak, (unknown), (unknown), (unknown), Timothy M. Pawlik, Antoni Szczepanik, Piotr Richter, Marek Sierżęga, Wojciech Polkowski, Karol Rawicz‐Pruszyński	0
5	IL1B Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients 2024 ·Cancers ·(unknown), (unknown), Iwona Homa‐Mlak, Marek Hus, Teresa Małecka‐Massalska, Radosław Mlak	1
6	The Depressiveness, Quality of Life and NEO-FFI Scale in Patients with Selected Genodermatoses 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), Radosław Mlak, (unknown), Katarzyna Wertheim‐Tysarowska, Anette Bygum, (unknown), Dariusz Matosiuk, Aldona Pietrzak	0
7	A Virome and Proteomic Analysis of Placental Microbiota in Pregnancies with and without Fetal Growth Restriction 2024 ·Cells ·(unknown), (unknown), (unknown), Anna Kwaśniewska, Radosław Mlak, Robert Nawrot, Anna Goździcka‐Józefiak, Wojciech Kwaśniewski	1
8	Prognostic Value of Inflammatory Burden Index in Advanced Gastric Cancer Patients Undergoing Multimodal Treatment 2024 ·Cancers ·(unknown), (unknown), Radosław Mlak, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Magdalena Skórzewska, Wojciech Polkowski, Timothy M. Pawlik, Karol Rawicz‐Pruszyński	12
9	The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma 2023 ·Cells ·(unknown), Radosław Mlak, (unknown), (unknown), Sylwia Chocholska, (unknown), (unknown), Michał Szczyrek, Iwona Homa‐Mlak, (unknown), Teresa Małecka‐Massalska, Marek Hus	1
10	Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Radosław Mlak, Yutaka Endo, (unknown), Andrzej Kurylcio, Wojciech Polkowski, Timothy M. Pawlik, Karol Rawicz‐Pruszyński	1
11	A Propensity Score Matched Analysis of Superparamagnetic Iron Oxide versus Radioisotope Sentinel Node Biopsy in Breast Cancer Patients after Neoadjuvant Chemotherapy 2022 ·Cancers ·(unknown), Magdalena Skórzewska, (unknown), Tomasz Nowikiewicz, Radosław Mlak, (unknown), (unknown), Karol Rawicz‐Pruszyński, Wojciech Zegarski, Wojciech Polkowski, Andrzej Kurylcio	8
12	Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma 2022 ·Cells ·(unknown), Radosław Mlak, Michał Mielnik, (unknown), Sylwia Chocholska, (unknown), Michał Szczyrek, Iwona Homa‐Mlak, Teresa Małecka‐Massalska, Marek Hus	5
13	Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer 2021 ·Cancers ·Michał Szczyrek, Anna Grenda, Barbara Kuźnar-Kamińska, Paweł Krawczyk, Marek Sawicki, Halina Batura‐Gabryel, Radosław Mlak, (unknown), (unknown), (unknown), Janusz Milanowski	5
14	Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy 2021 ·Journal of Clinical Medicine ·Iwona Homa‐Mlak, Anna Brzozowska, Radosław Mlak, (unknown), Teresa Małecka‐Massalska	15
15	Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients 2020 ·British Journal of Haematology ·(unknown), Radosław Mlak, (unknown), Michał Mielnik, (unknown), (unknown), (unknown), Iwona Homa‐Mlak, Michał Szczyrek, Janusz Krawczyk, Teresa Małecka‐Massalska, Marek Hus	18
16	Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen 2020 ·Annals of Hematology ·(unknown), Radosław Mlak, Michał Mielnik, Michał Szczyrek, (unknown), Iwona Homa‐Mlak, Szymon Zmorzyński, (unknown), (unknown), Agata Filip, Teresa Małecka‐Massalska, Marek Hus	16
17	Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide‐based chemotherapy in multiple myeloma patients 2019 ·British Journal of Haematology ·Radosław Mlak, (unknown), (unknown), Michał Szczyrek, Iwona Homa‐Mlak, Michał Mielnik, Sylwia Chocholska, (unknown), Teresa Małecka‐Massalska, Marek Hus	7
18	The Presence of HER2 Exon 20 Insertion in Patients with Central Nervous System Metastases from Non-Small Lung Cancer—A Potential Application in Classification for Therapy 2013 ·Advances in respiratory medicine ·Marcin Nicoś, Paweł Krawczyk, Radosław Mlak, Marek Sawicki, Bożena Jarosz, Tomasz Powrózek, (unknown), Tomasz Trojanowski, Janusz Milanowski	4
19	Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer — a pilot study 2012 ·SHILAP Revista de lepidopterología ·Janusz Milanowski, Beata Biernacka, Radosław Mlak, Tomasz Kucharczyk, Kamila Wojas‐Krawczyk, Paweł Krawczyk	1
20	Czynniki biochemiczne i genetyczne w diagnostyce i prognozowaniu przebiegu chorób nowotworowych 2010 ·Via Medica Journals ·Radosław Mlak, Paweł Krawczyk, Janusz Milanowski	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact